Incyte (INCY) Capital Expenditures (2009 - 2026)
Incyte (INCY) reported Capital Expenditures of $15.63 million for Q3 2026, up 6.0% from $14.75 million a year earlier and up 25.9% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Incyte's Capital Expenditures came in at $60.12 million, up 10.6% year-over-year; for FY2025, it was $58.87 million, down 31.8% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $86.26 million in FY2024 (+165.5%), $32.49 million in FY2023 (-58.3%), $77.83 million in FY2022 (-57.0%) and $181.01 million in FY2021 (-3.4%).
- Five-year quarterly Capital Expenditures spans a low of $2.27 million in Q4 2023 and a high of $54.14 million in Q2 2024.
- Year over year, Capital Expenditures gained in five of the last eight quarters, with growth averaging 117.3%.
- The high point for year-over-year Capital Expenditures in five years was Q4 2024 (growth of 666.8%); the low point was Q4 2023 (a decline of 89.3%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $12.41 million (Q2 2026), $10.2 million (Q1 2026) and $21.88 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 15.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.63 Mn |
| Jun 30, 2026 | 12.41 Mn |
| Mar 31, 2026 | 10.20 Mn |
| Dec 31, 2025 | 21.88 Mn |
| Sep 30, 2025 | 14.75 Mn |
| Jun 30, 2025 | 19.07 Mn |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | 17.38 Mn |
| Sep 30, 2024 | 5.19 Mn |
| Jun 30, 2024 | 54.14 Mn |
| Mar 31, 2024 | 9.55 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 10.98 Mn |
| Jun 30, 2023 | 7.34 Mn |
| Mar 31, 2023 | 11.91 Mn |
| Dec 31, 2022 | 21.27 Mn |
| Sep 30, 2022 | 27.81 Mn |
| Jun 30, 2022 | 11.74 Mn |
| Mar 31, 2022 | 17.01 Mn |
| Dec 31, 2021 | 34.46 Mn |
API Access
Incyte Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();